Protocol MCC-257/A04, Long-term Safety and Efficacy Study of Open-label Treatment with 80 mg MCC-257, in Patients with Mild to Moderate Diabetic Polyneuropathy: A 24-Week
|Effective start/end date||8/22/06 → 5/31/08|
- MEDPACE, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.